These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 10640988

  • 1. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 2. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493
    [Abstract] [Full Text] [Related]

  • 3. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB, Mikaelsdottir EK, Vidarsson H, Jónasson JG, Olafsdóttir K, Kristjánsdóttir K, Kjartansson J, Ogmundsdóttir HM, Rafnar T.
    Br J Cancer; 2000 Dec 15; 83(12):1715-21. PubMed ID: 11104571
    [Abstract] [Full Text] [Related]

  • 4. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 15; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 6. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW, Papayoti MH, Netto G, Armstrong DT, Ordonez G, Lawson JM, Stone MJ.
    Clin Cancer Res; 2001 Mar 15; 7(3):691-703. PubMed ID: 11297266
    [Abstract] [Full Text] [Related]

  • 7. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK, Shanahan F.
    J Pathol; 1998 Nov 15; 186(3):240-6. PubMed ID: 10211111
    [Abstract] [Full Text] [Related]

  • 8. FasL:Fas ratio--a prognostic factor in breast carcinomas.
    Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen HJ.
    Cancer Res; 2000 Feb 15; 60(4):822-8. PubMed ID: 10706087
    [Abstract] [Full Text] [Related]

  • 9. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
    Lee SH, Shin MS, Lee JY, Park WS, Kim SY, Jang JJ, Dong SM, Na EY, Kim CS, Kim SH, Yoo NJ.
    J Pathol; 1999 Jun 15; 188(2):207-12. PubMed ID: 10398166
    [Abstract] [Full Text] [Related]

  • 10. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K.
    Int J Oncol; 2001 Jan 15; 18(1):33-9. PubMed ID: 11115536
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 12. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH, Shin MS, Lee HS, Bae JH, Lee HK, Kim HS, Kim SY, Jang JJ, Joo M, Kang YK, Park WS, Park JY, Oh RR, Han SY, Lee JH, Kim SH, Lee JY, Yoo NJ.
    Hum Pathol; 2001 Mar 15; 32(3):250-6. PubMed ID: 11274632
    [Abstract] [Full Text] [Related]

  • 13. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R.
    Br J Cancer; 2000 May 15; 82(10):1682-8. PubMed ID: 10817504
    [Abstract] [Full Text] [Related]

  • 14. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 15; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 15. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 16. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells.
    Jiang S, Moriarty SE, Grossniklaus H, Nelson KC, Jones DP, Sternberg P.
    Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2546-53. PubMed ID: 12147583
    [Abstract] [Full Text] [Related]

  • 17. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 18. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
    Perabo FG, Kamp S, Schmidt D, Lindner H, Steiner G, Mattes RH, Wirger A, Pegelow K, Albers P, Kohn EC, von Ruecker A, Mueller SC.
    Br J Cancer; 2001 May 18; 84(10):1330-8. PubMed ID: 11355943
    [Abstract] [Full Text] [Related]

  • 19. Fas ligand is constitutively secreted by prostate cancer cells in vitro.
    Liu QY, Rubin MA, Omene C, Lederman S, Stein CA.
    Clin Cancer Res; 1998 Jul 18; 4(7):1803-11. PubMed ID: 9676859
    [Abstract] [Full Text] [Related]

  • 20. Human lung carcinomas express Fas ligand.
    Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA.
    Cancer Res; 1997 Mar 15; 57(6):1007-12. PubMed ID: 9067260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.